Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

PubWeight™: 7.44‹?› | Rank: Top 0.1%

🔗 View Article (PMC 2631136)

Published in Neoplasia on February 01, 2009

Authors

Anwar R Padhani1, Guoying Liu, Dow Mu Koh, Thomas L Chenevert, Harriet C Thoeny, Taro Takahara, Andrew Dzik-Jurasz, Brian D Ross, Marc Van Cauteren, David Collins, Dima A Hammoud, Gordon J S Rustin, Bachir Taouli, Peter L Choyke

Author Affiliations

1: Mount Vernon Cancer Centre, London, UK.

Associated clinical trials:

PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy | NCT02433301

Articles citing this

(truncated to the top 100)

Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med (2010) 3.62

Radiomics: the process and the challenges. Magn Reson Imaging (2012) 2.65

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology (2010) 2.38

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol (2015) 2.21

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging (2010) 2.18

A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol (2009) 2.10

Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging (2010) 1.82

Quantitative imaging for evaluation of response to cancer therapy. Transl Oncol (2009) 1.66

Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom. J Magn Reson Imaging (2012) 1.57

Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol (2012) 1.56

ESR statement on the stepwise development of imaging biomarkers. Insights Imaging (2013) 1.51

Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies. J Magn Reson Imaging (2011) 1.50

Diffusion Magnetic Resonance Imaging: What Water Tells Us about Biological Tissues. PLoS Biol (2015) 1.46

RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline. Eur Radiol (2009) 1.44

Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol (2010) 1.42

Survival analysis for apparent diffusion coefficient measures in children with embryonal brain tumours. Neuro Oncol (2012) 1.40

Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39

The Therapeutic Response of Gastrointestinal Stromal Tumors to Imatinib Treatment Assessed by Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Histopathological Correlation. PLoS One (2016) 1.39

Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol (2011) 1.38

Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol (2010) 1.37

The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol (2010) 1.36

Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magn Reson Med (2011) 1.36

Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med (2012) 1.34

Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas. J Neurooncol (2010) 1.31

Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI. NMR Biomed (2011) 1.30

Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol (2011) 1.29

Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol (2012) 1.28

Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma. Neuro Oncol (2012) 1.28

Imaging ovarian cancer and peritoneal metastases--current and emerging techniques. Nat Rev Clin Oncol (2010) 1.26

APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. Int J Hepatol (2011) 1.24

Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts. Korean J Radiol (2012) 1.24

Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes. Eur Radiol (2012) 1.22

The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis. PLoS One (2013) 1.22

Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeletal Radiol (2011) 1.21

Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol (2010) 1.21

ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Neuroradiology (2010) 1.20

Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer (2014) 1.18

Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab. Neuro Oncol (2011) 1.17

White paper on imaging biomarkers. Insights Imaging (2010) 1.15

MR elastography of liver tumours: value of viscoelastic properties for tumour characterisation. Eur Radiol (2012) 1.15

Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results. Eur Radiol (2011) 1.13

Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma. PLoS One (2011) 1.12

Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review. Insights Imaging (2012) 1.11

Clinically relevant modeling of tumor growth and treatment response. Sci Transl Med (2013) 1.11

MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol (2011) 1.11

Comparisons of the efficacy of a Jak1/2 inhibitor (AZD1480) with a VEGF signaling inhibitor (cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology. Neoplasia (2012) 1.10

Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol (2012) 1.10

Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol (2013) 1.09

Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI. Magn Reson Med (2010) 1.09

Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol (2010) 1.09

The role of tissue microstructure and water exchange in biophysical modelling of diffusion in white matter. MAGMA (2013) 1.09

Diffusion-weighted imaging in head and neck cancers. Future Oncol (2009) 1.08

The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer. Semin Oncol (2011) 1.07

Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma. Neuroradiology (2010) 1.07

Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol (2011) 1.07

Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol (2011) 1.07

Influence of selected b values on ADC quantification in diffusion-weighted MRI. Comment on Punwani et al.: Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging (2013) 1.06

Characterizing tumor response to chemotherapy at various length scales using temporal diffusion spectroscopy. PLoS One (2012) 1.05

Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. J Magn Reson Imaging (2013) 1.05

Magnetic resonance imaging of the chest in the evaluation of cancer patients: state of the art. Radiol Bras (2015) 1.04

Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria. Radiology (2013) 1.03

True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis. Korean J Radiol (2013) 1.01

Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy. Eur Radiol (2013) 0.99

Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol (2016) 0.99

Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomas. J Magn Reson Imaging (2010) 0.99

The emerging role of diffusion-weighted MRI in prostate cancer management. Nat Rev Urol (2012) 0.99

Optimising diffusion-weighted MR imaging for demonstrating pancreatic cancer: a comparison of respiratory-triggered, free-breathing and breath-hold techniques. Eur Radiol (2012) 0.99

Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer. Top Magn Reson Imaging (2008) 0.99

Regional and whole-body imaging in pediatric oncology. Pediatr Radiol (2011) 0.99

Analysis and correction of gradient nonlinearity bias in apparent diffusion coefficient measurements. Magn Reson Med (2014) 0.98

Quantitative liver ADC measurements using diffusion-weighted MRI at 3 Tesla: evaluation of reproducibility and perfusion dependence using different techniques for respiratory compensation. MAGMA (2013) 0.98

In vitro and in vivo repeatability of abdominal diffusion-weighted MRI. Br J Radiol (2012) 0.98

The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function. Br J Cancer (2012) 0.98

In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging. Med Phys (2012) 0.97

Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation. World J Gastroenterol (2013) 0.97

The value of apparent diffusion coefficient in the assessment of cervical cancer. Eur Radiol (2012) 0.97

Bony metastases: assessing response to therapy with whole-body diffusion MRI. Cancer Imaging (2011) 0.97

Diffusion weighted imaging in prostate cancer. Eur Radiol (2010) 0.95

Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation. Eur Radiol (2012) 0.95

Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation. Pharmaceutics (2012) 0.94

Diffusion-weighted MRI for assessment of early cancer treatment response. Curr Pharm Biotechnol (2010) 0.94

Implementation of dual-source RF excitation in 3 T MR-scanners allows for nearly identical ADC values compared to 1.5 T MR scanners in the abdomen. PLoS One (2012) 0.93

Indeterminate adnexal masses at ultrasound: effect of MRI imaging findings on diagnostic thinking and therapeutic decisions. Eur Radiol (2010) 0.93

Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies? Br J Cancer (2012) 0.93

Radiotherapy planning using MRI. Phys Med Biol (2015) 0.93

Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol (2010) 0.93

Whole-body magnetic resonance imaging in children: state of the art. Radiol Bras (2015) 0.93

Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy. J Oncol (2010) 0.93

Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours. Eur Radiol (2010) 0.93

Diffusion-weighted MR imaging for characterizing musculoskeletal lesions. Radiographics (2014) 0.93

Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol (2013) 0.92

Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkers. Clin Cancer Res (2014) 0.92

Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla. Eur J Nucl Med Mol Imaging (2011) 0.92

Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques. J Magn Reson Imaging (2013) 0.92

Multiparametric magnetic resonance imaging of the prostate: current concepts. Radiol Bras (2015) 0.92

Functional MRI for radiotherapy dose painting. Magn Reson Imaging (2012) 0.92

Uncertainty in assessment of radiation-induced diffusion index changes in individual patients. Phys Med Biol (2013) 0.92

Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography. Br J Cancer (2014) 0.92

Oscillating and pulsed gradient diffusion magnetic resonance microscopy over an extended b-value range: implications for the characterization of tissue microstructure. Magn Reson Med (2012) 0.92

Characterization of soft tissue masses: can quantitative diffusion weighted imaging reliably distinguish cysts from solid masses? Skeletal Radiol (2013) 0.92

Articles cited by this

Diffusion tensor MR imaging of the human brain. Radiology (1996) 9.84

Fiber tracking: principles and strategies - a technical review. NMR Biomed (2002) 8.52

Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology (1988) 8.08

Reduction of eddy-current-induced distortion in diffusion MRI using a twice-refocused spin echo. Magn Reson Med (2003) 8.06

Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology (1990) 6.12

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst (2000) 5.14

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging (1999) 4.94

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A (2005) 4.63

Processing and visualization for diffusion tensor MRI. Med Image Anal (2002) 4.60

Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology (1990) 4.42

The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol (2001) 3.58

Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med (2004) 3.48

Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging (2002) 3.35

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A (2005) 3.15

Basic principles of diffusion-weighted imaging. Eur J Radiol (2003) 2.93

Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology (2003) 2.75

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging (2006) 2.69

Biexponential diffusion attenuation in various states of brain tissue: implications for diffusion-weighted imaging. Magn Reson Med (1996) 2.62

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol (2007) 2.39

Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet (2002) 2.38

Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology (2008) 2.34

Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging (2006) 2.26

Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med (2003) 2.25

Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia (1999) 2.24

Multi-component apparent diffusion coefficients in human brain. NMR Biomed (1999) 2.21

Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology (1999) 2.19

Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology (2005) 2.18

Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology (2007) 2.18

Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia (2005) 2.17

Test liquids for quantitative MRI measurements of self-diffusion coefficient in vivo. Magn Reson Med (2000) 2.14

Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol (2003) 2.10

Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol (2003) 2.06

Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr (2005) 2.05

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol (2008) 2.05

Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol (2008) 2.03

In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging (2002) 2.01

Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke (1998) 1.96

Characterization of and correction for eddy current artifacts in echo planar diffusion imaging. Magn Reson Med (1998) 1.94

Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol (1998) 1.80

Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol (2004) 1.74

The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment. NMR Biomed (2001) 1.74

Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol (2008) 1.71

Validation of an acute ischemic stroke model: does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke (2007) 1.65

ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol (2006) 1.62

Diffusion-weighted MRI postoperative assessment of an epidermoid tumour in the cerebellopontine angle. Neuroradiology (1999) 1.61

Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T. Radiol Med (2008) 1.58

Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys (2003) 1.57

Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology (2006) 1.57

Temperature mapping with MR imaging of molecular diffusion: application to hyperthermia. Radiology (1989) 1.56

Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol (2007) 1.55

Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging (1999) 1.46

Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. Anticancer Res (2005) 1.46

Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results. Eur Radiol (2006) 1.45

Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology (2007) 1.43

High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol (2006) 1.41

Effects of equilibrium exchange on diffusion-weighted NMR signals: the diffusigraphic "shutter-speed". Magn Reson Med (2003) 1.38

Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med (2008) 1.36

Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology (2005) 1.35

Diffusion MRI: apparent diffusion coefficient (ADC) values in the normal brain and a classification of brain disorders based on ADC values. Comput Med Imaging Graph (2001) 1.35

Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. Eur Radiol (2006) 1.32

Quality control for functional magnetic resonance imaging using automated data analysis and Shewhart charting. Magn Reson Med (1999) 1.25

Developing a quality control protocol for diffusion imaging on a clinical MRI system. Phys Med Biol (2004) 1.24

Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging. Radiology (2006) 1.22

Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol (2007) 1.20

Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol (2006) 1.19

Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration. Neoplasia (2005) 1.18

Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol (2008) 1.16

A phantom for diffusion-weighted imaging of acute stroke. J Magn Reson Imaging (1999) 1.10

The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci (2006) 1.08

Mapping eddy current induced fields for the correction of diffusion-weighted echo planar images. Magn Reson Imaging (1999) 1.07

Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma. Neuroradiology (2006) 1.07

The role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions: a report of 147 lesions. Surg Neurol (2006) 1.04

A model for diffusive transport through a spherical interface probed by pulsed-field gradient NMR. Biophys J (1998) 1.01

Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials. J Clin Oncol (2000) 1.01

Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol (2008) 0.98

Phantom-based evaluation of geometric distortions in functional magnetic resonance and diffusion tensor imaging. Magn Reson Med (2007) 0.96

Monitoring of acute generalized status epilepticus using multilocal diffusion MR imaging: early prediction of regional neuronal damage. AJNR Am J Neuroradiol (2007) 0.95

Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate. Neuro Oncol (2007) 0.92

Laryngeal and hypopharyngeal carcinomas after (chemo)radiotherapy: a diagnostic dilemma. Curr Opin Otolaryngol Head Neck Surg (2008) 0.92

Principal component and linear discriminant analysis of T1 histograms of white and grey matter in multiple sclerosis. Magn Reson Imaging (2006) 0.90

Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions. Eur Radiol (2007) 0.90

Geometric direct search algorithms for image registration. IEEE Trans Image Process (2007) 0.86

Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy. Cancer Invest (2007) 0.86

Articles by these authors

Large-scale genotyping of complex DNA. Nat Biotechnol (2003) 10.00

Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods (2004) 9.52

Genome-wide detection of human copy number variations using high-density DNA oligonucleotide arrays. Genome Res (2006) 5.97

Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum Genomics (2004) 5.65

Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res (2004) 5.59

Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (2011) 5.53

Imaging of angiogenesis: from microscope to clinic. Nat Med (2003) 5.51

Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays. Bioinformatics (2005) 5.01

Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol (2011) 4.99

Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet (2004) 4.76

Rapid cancer detection by topically spraying a γ-glutamyltranspeptidase-activated fluorescent probe. Sci Transl Med (2011) 4.72

Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol (2013) 4.64

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A (2005) 4.63

Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med (2010) 4.15

Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) (2008) 4.08

Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol (2011) 4.01

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol (2006) 3.98

Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med (2007) 3.88

Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol (2011) 3.56

Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med (2004) 3.48

Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol (2011) 3.44

New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev (2010) 3.35

Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet (2005) 3.26

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A (2005) 3.15

Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med (2008) 3.15

Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials (2007) 3.12

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Radiology (2010) 3.12

Description of the data from the Collaborative Study on the Genetics of Alcoholism (COGA) and single-nucleotide polymorphism genotyping for Genetic Analysis Workshop 14. BMC Genet (2005) 3.04

Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med (2012) 2.95

Influence of attitudes toward curriculum on dishonest academic behavior. Am J Pharm Educ (2006) 2.91

Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol (2010) 2.90

Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol (2008) 2.84

CARAT: a novel method for allelic detection of DNA copy number changes using high density oligonucleotide arrays. BMC Bioinformatics (2006) 2.82

Imaging prostate cancer: a multidisciplinary perspective. Radiology (2007) 2.79

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer). J Natl Cancer Inst (2004) 2.79

Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med (2011) 2.76

Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A (2007) 2.71

Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience. Radiology (2005) 2.69

Algorithms for large-scale genotyping microarrays. Bioinformatics (2003) 2.66

Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol (2013) 2.62

Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol (2012) 2.59

It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging (2002) 2.58

Towards hyperpolarized (13)C-succinate imaging of brain cancer. J Magn Reson (2007) 2.57

Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol (2012) 2.55

Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology (2012) 2.53

In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res (2009) 2.51

Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res (2006) 2.46

Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett (2007) 2.46

11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med (2012) 2.42

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol (2007) 2.39

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology (2010) 2.38

Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol (2003) 2.35

Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology (2013) 2.35

Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology (2008) 2.34

The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol (2004) 2.32

The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med (2009) 2.32

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia (2006) 2.30

Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther (2003) 2.28

Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood (2004) 2.27

PASADENA hyperpolarization of succinic acid for MRI and NMR spectroscopy. J Am Chem Soc (2008) 2.27

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed (2002) 2.24

Toxicity of organic fluorophores used in molecular imaging: literature review. Mol Imaging (2009) 2.21

MRI of tumor angiogenesis. J Magn Reson Imaging (2007) 2.19

Clinical features of 8 cases of orbital sparganosis in southern China. Can J Ophthalmol (2012) 2.16

Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer (2012) 2.15

Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. J Clin Oncol (2011) 2.14

Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology (2015) 2.11

D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol (2011) 2.10

A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol (2009) 2.10

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol (2008) 2.05

NetAffx Gene Ontology Mining Tool: a visual approach for microarray data analysis. Bioinformatics (2004) 2.02

In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies. Clin Cancer Res (2007) 2.01

Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer (2013) 1.97

Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging (2010) 1.96

Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A (2002) 1.93

Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol (2007) 1.92

Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol (2009) 1.89

Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int (2007) 1.86

Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging (2010) 1.82

Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations. Lancet Oncol (2007) 1.80

Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett (2006) 1.80

Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. Int J Radiat Oncol Biol Phys (2005) 1.79

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol (2013) 1.77

Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res (2007) 1.76

Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol (2010) 1.76

Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol (2009) 1.76

Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. Acc Chem Res (2010) 1.74

Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol (2002) 1.74

Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci (2003) 1.72

Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. ACS Nano (2007) 1.70

Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging (2010) 1.70